Staff turnover in EUR1.213.4441.315.6741.403.8771.458.4281.762.595
Staff turnover in EUR1.213.4441.315.6741.403.8771.458.4281.762.595
Die Aktie: Angaben in EURO20212022202320242025
Aktien im Umlauf (in Mio.)2,002,002,00217,162,00
Dividende pro Aktie4.525.125.926.526.84
unverwässertes Ergebnis pro Aktie24,7324,8125,2225,6825,21
GuV in Mio. EURO nach IAS/IFRS20212022202320242025
Umsatz138.639,0156.595,0171.340,0176.810,0199.125,0
Operatives Ergebnis (EBIT)7.497,47.408,97.516,37.812,06.972,3
Ergebnis vor Steuer (EBT)7.925,07.769,07.715,07.904,06.710,0
Annual net profit/ loss6.104,06.025,05.987,05.980,05.662,0
Bilanz in Mio. EURO nach IAS/IFRS20212022202320242025
Aktiva
Summe Umlaufvermögen51.122,055.617,060.029,058.942,063.001,0
Summe Anlagevermögen46.338,047.155,048.899,057.947,058.493,0
Summe Aktiva97.460,0102.772,0108.928,0116.889,0121.494,0
Passiva
Summe kurzfristige Verbindlichkeiten34.885,039.696,041.791,040.581,041.035,0
Summe langfristige Verbindlichkeiten26.447,026.682,027.732,034.882,036.433,0
Summe Rückstellungen52,038,038,0-34,00,0
Summe Eigenkapital36.128,036.394,039.405,041.426,044.026,0
Summe Passiva97.460,0102.772,0108.928,0116.889,0121.494,0
Management:
Ramiro Peru
Bahija Jallal
Ryan Schneider
Amy Schulman
Antonio Neri
Deanna Strable-Soethout
Lewis Hay
Robert Dixon
Steven Collis
Susan DeVore
Gail K. Boudreaux
Mark Kaye
Ronald W. Penczek
Aufsichtsrat:
Aktionärsstruktur in %:
Adresse: 220 Virginia Avenue, 46204 Indianapolis
T: +1-833-401-1577
F: +
I: http://www.elevancehealth.com
E: